Drug intelligence / Profile preview

Skyvit-B

Development stage: Unknown
Lead developer: Skyways Healthcare
Modality: Small Molecules
Administration: Oral

Overview

Skyvit-B is a vitamin B-complex supplement marketed by Skyways Healthcare. It is a branded generic pharmaceutical formulation distributed through the company's PCD (Propaganda Cum Distribution) franchise model in India. The product is designed to provide a comprehensive blend of essential B vitamins, which serve as vital cofactors for numerous enzymatic reactions involved in energy metabolism, neurological health, and the synthesis of red blood cells and DNA. Skyvit-B is used for the prevention and treatment of vitamin B deficiencies and to support overall nutritional status.

Brand names: Skyvit-B

Beyond the preview

Go deeper on Skyvit-B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skyvit-B.

Explore the full profile